Purchase Order FA864921P1587

Award Date 8/6/21
Potential Completion Date 11/9/22
Potential Value $750K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fayetteville, AR 72701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
297
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of the Air Force Materiel Command Research Laboratory to Nanomatronix LLC, a small business, for the development of the Advanced Microphysiological Brain Injury Technology (AMBIT) platform. The contract, valued at $149,999.00, is a Small Business Technology Transfer (STTR) Phase I research project with a firm-fixed price. Nanomatronix LLC has prior experience providing research and development services related to traumatic brain injury, artificial...
This is a $109,835.00 firm fixed price STTR Phase I contract awarded by the Air Force Research Laboratory to Nanomatronix LLC, a small business subchapter S corporation. The contract is for the enhancement of the Advanced Microphysiological Brain Injury Technology (AMBIT) into a completely xeno-free isogenic multicellular platform. The contract has a total small business set-aside designation and an ultimate completion date of August 19, 2024. Nanomatronix LLC has previously received prime...
This is a $74,934 firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Nanomatronix LLC, a small business, under the SBIR program. The contract modifies an existing advanced micro-physiological brain injury technology platform to include cerebral organoids. Nanomatronix LLC has a history of providing research and development services related to traumatic brain injury, AI, cryptography, fiber optics, and water recovery through past prime federal contracts, many...
The U.S. Army Medical Command (MEDCOM) has awarded a $1,099,993.64 Firm Fixed Price (FFP) contract to Nanomatronix LLC, a small business subchapter S corporation, for the continued development of the Advanced Microphysiological Brain Injury Technology (AMBIT) platform under a Small Business Innovation Research (SBIR) Phase II contract. This contract supports Nanomatronix's proposal titled "The AMBIT Platform: An In Vitro System for Traumatic Brain Injury R&D" and is set to be...
The U.S. Department of the Air Force Materiel Command Research Laboratory awarded a firm-fixed-price purchase order contract to Nanomatronix LLC, a small business subchapter S corporation, on December 5, 2020. The $149,997.00 contract is for the development of a ruggedized, low-swap, high-bandwidth and protocol reconfigurable fiber optic communications network for electric aircraft, as part of a Small Business Technology Transfer (STTR) Phase I research project. Nanomatronix LLC has previously...
This is a $1,445,985.00 cost-plus-fixed-fee definitive contract awarded by the Department of the Navy Naval Air Systems Command to Nanomatronix LLC, a small business subchapter S corporation, for research and development services under the Small Business Innovation Research (SBIR) Phase II program. The contract has a total small business set-aside designation. Nanomatronix LLC will provide research and development related to traumatic brain injury, artificial intelligence, cryptography, fiber...
The U.S. Air Force Research Laboratory awarded a $1,249,997 firm fixed price SBIR Phase II contract to Neurovation Labs Inc., a small disadvantaged, woman-owned business, to develop an objective biomedical diagnostic for assessing traumatic brain injury (TBI) and other trauma-related mental health conditions. This contract supports the Air Force's research into diagnostic tools for brain injuries faced by military personnel. Neurovation Labs has previously received a $49,920 SBIR Phase I award...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Air Force Materiel Command Research Laboratory to Lynntech Inc., a small business, to develop a Multi-Cell Human 3D Brain Model on Chip. The contract was awarded on December 12, 2019, with a completion date of December 14, 2020. As an SBIR Phase I award, this contract supports early-stage research and development of innovative technologies with potential defense and commercial...
This is a Small Business Innovation Research (SBIR) contract awarded by the Air Force Research Laboratory (AFRL) to Atom Limbs Inc. for continued service with mind-controlled artificial limbs. The firm-fixed-price purchase order has a ceiling value of $74,943 and a completion date of February 4, 2023. As an SBIR Phase I action, this contract supports research and development of innovative technologies for the U.S. Air Force. The contract was awarded on November 3, 2022 and is set aside for small...
Nanomatronix LLC has been awarded a definitive contract valued at $754,058 by the National Aeronautics and Space Administration (NASA) Shared Services Center. The firm fixed price contract is for continued research and development efforts originally initiated under Phase I of the Small Business Innovation Research (SBIR) program. Work will be performed in Fayetteville, Arkansas through November 2023. The contract has a total small business set aside designation. Nanomatronix will further develop...

Nanomatronix LLC has been awarded a $749,990 firm fixed price purchase order by the Air Force Materiel Command Research Laboratory to deliver the Advanced Microphysiological Brain Injury Technology (AMBIT) platform under Phase II of the Small Business Innovation Research program. As part of its research into traumatic brain injury, the Air Force laboratory utilizes the SBIR mechanism to transition promising technologies from small businesses into its programs. Nanomatronix will perform work at its Fayetteville, Arkansas location through November 2022 to further develop the AMBIT platform, a microfluidic cell-based system that models brain cell responses to injury. This contract has been set aside for total small business participation.

Generated 12/25/23, 1:47 AM